HYPERION DEFI, INC. Cost of Revenue
HYPERION DEFI, INC. (HYPD) reported Cost of Revenue of $303.29 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-13
- HYPERION DEFI, INC. cost of revenue for the quarter ending 2025-12-31 was $303.24K, a 90.22% decline year-over-year.
- HYPERION DEFI, INC. cost of revenue for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- HYPERION DEFI, INC. cost of revenue for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- HYPERION DEFI, INC. cost of revenue for the quarter ending 2025-03-31 was $48.00, a 99.98% decline year-over-year.
- HYPERION DEFI, INC. cost of revenue for fiscal 2025 was $303.29K, a 92.28% decline from fiscal 2024.
- HYPERION DEFI, INC. cost of revenue for fiscal 2024 was $3.93M, a 24437.51% increase from fiscal 2023.
- HYPERION DEFI, INC. cost of revenue for fiscal 2023 was $16.00K.
- HYPERION DEFI, INC. cost of revenue for fiscal 2021 was $1.60M, a 100.00% increase from fiscal 2020.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $303.24K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $303.24K derived: sum of 2 quarters · filed 2026-03-30 | $303.24K derived: sum of 3 quarters · filed 2026-08-13 | $303.29K 10-K · filed 2026-03-30 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $48.00 10-Q · filed 2025-11-14 | $3.10M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $48.00 10-Q · filed 2026-08-13 | $3.10M derived: sum of 3 quarters · filed 2026-08-13 | $3.23M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $48.00 10-Q · filed 2026-05-15 | $3.10M derived: sum of 2 quarters · filed 2026-05-15 | $3.23M derived: sum of 3 quarters · filed 2026-05-15 | $3.72M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.23M derived: sum of 2 quarters · filed 2026-03-30 | $3.72M derived: sum of 3 quarters · filed 2026-03-30 | $3.93M 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $132.52K 10-Q · filed 2025-11-14 | $622.88K derived: sum of 2 quarters · filed 2025-11-14 | $825.91K 10-Q · filed 2025-11-14 | $828.50K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $490.36K 10-Q · filed 2025-08-13 | $693.39K 10-Q · filed 2025-08-13 | $695.98K derived: sum of 3 quarters · filed 2025-08-13 | $709.39K derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $203.03K 10-Q · filed 2025-05-19 | $4.99K 10-Q · filed 2024-05-15 | $205.62K derived: sum of 2 quarters · filed 2025-05-19 | $219.03K derived: sum of 3 quarters · filed 2025-05-19 | |||
| 2023-12-31 | $2.59K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $16.00K derived: sum of 2 quarters · filed 2025-04-15 | $16.00K 10-K · filed 2025-04-15 | $3.79K 10-K · filed 2024-03-18 | |||
| 2023-09-30 | $13.42K 10-Q · filed 2024-11-12 | $1.20K 10-Q · filed 2023-11-13 | $13.42K 10-Q · filed 2024-11-12 | $1.20K 10-Q · filed 2023-11-13 | |||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $800.00K derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $800.00K derived: sum of 3 quarters · filed 2023-03-31 | $1.60M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $800.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.60M 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $800.00K 10-Q · filed 2022-08-11 | $1.60M 10-Q · filed 2022-08-11 | |||||
| 2021-03-31 | $800.00K 10-Q · filed 2022-05-13 | ||||||
| 2020-12-31 | $800.00K 10-K · filed 2022-03-30 | ||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |